Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Tosoni

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
The Oncologist|February 20, 2019
Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?Enrico Franceschi, Alicia Tosoni, Dario De Biase, et al.
Frontiers in Oncology|December 4, 2025
How to predict progression-free survival in patients with grade 2 IDH-mutated diffuse gliomas after surgery: a long-term follow-up analysisMarta Aprile, Vincenzo Di Nunno, Lidia Gatto, et al.
Neuro-Oncology|February 20, 2010
O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implicationsAlba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
Scientific Reports|December 20, 2025
Occupational exposure and risk clusters in malignant transformation of inverted sinonasal papillomaGiulia Querzoli, Angela Camagni, Anna Caterina Leucci, et al.
Biomedicines|October 29, 2025
Gender- and Grade-Dependent Activation of Androgen Receptor Signaling in Adult-Type Diffuse Gliomas: Epigenetic Insights from a Retrospective Cohort StudyLidia Gatto, Sofia Asioli, Luca Morandi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2020
Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomasEnrico Franceschi, Alicia Tosoni, Stefania Bartolini, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|May 19, 2026
Is there a role for adjuvant radiotherapy after partial laryngectomy? A propensity score matched analysisLiliana Belgioia, Ida D'Onofrio, Marta Filauro, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory StudyValentina D A Corino, Marco Bologna, Giuseppina Calareso, et al.
Critical Reviews in Oncology/Hematology|June 4, 2026
Brain tumor susceptibility: from genetic predisposition syndromes to extended characterization of genomic determinantsMarta Aprile, Vanessa Callegari, Selene Cipri, et al.
Future Oncology (London, England)|February 17, 2016
Patient outcomes following second surgery for recurrent glioblastomaAlba A Brandes, Marco Bartolotti, Alicia Tosoni, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
The Oncologist|February 20, 2019
Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?Enrico Franceschi, Alicia Tosoni, Dario De Biase, et al.
Frontiers in Oncology|December 4, 2025
How to predict progression-free survival in patients with grade 2 IDH-mutated diffuse gliomas after surgery: a long-term follow-up analysisMarta Aprile, Vincenzo Di Nunno, Lidia Gatto, et al.
Neuro-Oncology|February 20, 2010
O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implicationsAlba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
Scientific Reports|December 20, 2025
Occupational exposure and risk clusters in malignant transformation of inverted sinonasal papillomaGiulia Querzoli, Angela Camagni, Anna Caterina Leucci, et al.
Biomedicines|October 29, 2025
Gender- and Grade-Dependent Activation of Androgen Receptor Signaling in Adult-Type Diffuse Gliomas: Epigenetic Insights from a Retrospective Cohort StudyLidia Gatto, Sofia Asioli, Luca Morandi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2020
Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomasEnrico Franceschi, Alicia Tosoni, Stefania Bartolini, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|May 19, 2026
Is there a role for adjuvant radiotherapy after partial laryngectomy? A propensity score matched analysisLiliana Belgioia, Ida D'Onofrio, Marta Filauro, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory StudyValentina D A Corino, Marco Bologna, Giuseppina Calareso, et al.
Critical Reviews in Oncology/Hematology|June 4, 2026
Brain tumor susceptibility: from genetic predisposition syndromes to extended characterization of genomic determinantsMarta Aprile, Vanessa Callegari, Selene Cipri, et al.
Future Oncology (London, England)|February 17, 2016
Patient outcomes following second surgery for recurrent glioblastomaAlba A Brandes, Marco Bartolotti, Alicia Tosoni, et al.
Pageof 11